Skip to main content
Top
Published in: Abdominal Radiology 6/2004

01-11-2004 | Original article

Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS

Authors: B. Kumbasar, I. R. Kamel, A. Tekes, J. Eng, E. K. Fishman, R. L. Wahl

Published in: Abdominal Radiology | Issue 6/2004

Login to get access

Abstract

Background: We retrospectively compared the accuracy of somatostatin receptor scintigraphy (SRS) with that of helical computed tomography (CT) in the detection and localization of primary and metastatic neuroendocrine tumors.
Methods: A medical record search identified 27 patients with known or clinically suspected neuroendocrine tumors who underwent helical CT and SRS within 3 months of one another at our institution. CT images were evaluated retrospectively by two blinded radiologists who used consensus reading. Images were evaluated for the presence or absence of primary tumor and hepatic and extrahepatic metastases. CT results were compared with the SRS report as interpreted by the nuclear medicine physicians. The results of the surgical, clinical follow-up, and pathologic findings were considered as the gold standard. Sensitivity, specificity, and accuracy were calculated for both imaging techniques. In addition, McNemar analysis was performed to determine statistically significant differences between CT and SRS.
Results: Helical CT was more sensitive than SRS in the detection of extrahepatic metastases, and the difference between the two imaging modalities was statistically significant (p = 0.0312) as determined by the McNemar chi-square test. However, the difference between CT and SRS in detecting primary neuroendocrine tumors, hepatic metastasis, and combined hepatic and extrahepatic metastasis was not statistically significant (p = 0.625, 1.000, and 1.000, respectively).
Conclusion: Helical CT and SRS have similar sensitivity, specificity, and accuracy in detecting primary neuroendocrine tumor and hepatic metastasis. However, helical CT appears to be more sensitive in detecting extrahepatic metastasis from primary neuroendocrine tumors.
Literature
go back to reference Pearse, AG 1969The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the conceptJ Histochem Cytochem17303313PubMed Pearse, AG 1969The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the conceptJ Histochem Cytochem17303313PubMed
go back to reference Lobrano, MB, McCarthy, K, Adams, L, Neitzschman, H 1997Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case reportAm J Gastroenterol92513515PubMed Lobrano, MB, McCarthy, K, Adams, L, Neitzschman, H 1997Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case reportAm J Gastroenterol92513515PubMed
go back to reference Kwekkeboom, DJ, Lamberts, SW, Habbema, JD, Krenning, EP 1996Cost-effectiveness analysis of somatostatin receptor scintigraphyJ Nucl Med37886892PubMed Kwekkeboom, DJ, Lamberts, SW, Habbema, JD, Krenning, EP 1996Cost-effectiveness analysis of somatostatin receptor scintigraphyJ Nucl Med37886892PubMed
go back to reference King, CM, Reznek, RH, Bomanji, J, et al. 1993Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative studyClin Radiol48386391PubMed King, CM, Reznek, RH, Bomanji, J,  et al. 1993Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative studyClin Radiol48386391PubMed
go back to reference Shi, W, Johnston, CF, Buchanan, KD, et al. 1998Localization of neuroendocrine tumours with [111In]DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imagingQJM91295301CrossRefPubMed Shi, W, Johnston, CF, Buchanan, KD,  et al. 1998Localization of neuroendocrine tumours with [111In]DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imagingQJM91295301CrossRefPubMed
go back to reference Kamel, IR, Choti, MA, Horton, KM, et al. 2003Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterizationRadiology227752757PubMed Kamel, IR, Choti, MA, Horton, KM,  et al. 2003Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterizationRadiology227752757PubMed
go back to reference Hopper, KD, Singapuri, K, Finkel, A 2000Body CT and oncologic imagingRadiology2152740PubMed Hopper, KD, Singapuri, K, Finkel, A 2000Body CT and oncologic imagingRadiology2152740PubMed
go back to reference Valls, C, Andia, E, Sanchez, A, et al. 2001Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CTRadiology2185560PubMed Valls, C, Andia, E, Sanchez, A,  et al. 2001Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CTRadiology2185560PubMed
go back to reference Frucht, H, Doppman, JL, Norton, JA, et al. 1989Gastrinomas: comparison of MR imaging with CT, angiography, and USRadiology171713717PubMed Frucht, H, Doppman, JL, Norton, JA,  et al. 1989Gastrinomas: comparison of MR imaging with CT, angiography, and USRadiology171713717PubMed
go back to reference Slooter, GD, Mearadji, A, Breeman, WA, et al. 2001Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumoursBr J Surg883140CrossRefPubMed Slooter, GD, Mearadji, A, Breeman, WA,  et al. 2001Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumoursBr J Surg883140CrossRefPubMed
go back to reference Kvols, LK, Buck, M, Moertel, CG, et al. 1987Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)Ann Intern Med107162168PubMed Kvols, LK, Buck, M, Moertel, CG,  et al. 1987Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)Ann Intern Med107162168PubMed
go back to reference Mahler, C, Verhelst, J, de Longueville, M, Harris, A 1990Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotideClin Endocrinol (Oxf)33261269 Mahler, C, Verhelst, J, de Longueville, M, Harris, A 1990Long-term treatment of metastatic medullary thyroid carcinoma with the somatostatin analogue octreotideClin Endocrinol (Oxf)33261269
go back to reference Fishman, EK 2001From the RSNA refresher courses: CT angiography: clinical applications in the abdomenRadiographics21S3S16PubMed Fishman, EK 2001From the RSNA refresher courses: CT angiography: clinical applications in the abdomenRadiographics21S3S16PubMed
go back to reference Rydberg, J, Buckwalter, KA, Caldemeyer, KS, et al. 2000Multisection CT: scanning techniques and clinical applicationsRadiographics2017871806PubMed Rydberg, J, Buckwalter, KA, Caldemeyer, KS,  et al. 2000Multisection CT: scanning techniques and clinical applicationsRadiographics2017871806PubMed
go back to reference Ji, H, McTavish, JD, Mortele, KJ, et al. 2001Hepatic imaging with multidetector CTRadiographics21S71S80PubMed Ji, H, McTavish, JD, Mortele, KJ,  et al. 2001Hepatic imaging with multidetector CTRadiographics21S71S80PubMed
go back to reference Lamberts, SW, Reubi, JC, Bakker, WH, Krenning, EP 1990Somatostatin receptor imaging with 123I-Tyr3-octreotideZ Gastroenterol282021PubMed Lamberts, SW, Reubi, JC, Bakker, WH, Krenning, EP 1990Somatostatin receptor imaging with 123I-Tyr3-octreotideZ Gastroenterol282021PubMed
go back to reference Kisker, O, Weinel, RJ, Geks, J, et al. 1996Value of somatostatin receptor scintigraphy for preoperative localization of carcinoidsWorld J Surg20162167CrossRefPubMed Kisker, O, Weinel, RJ, Geks, J,  et al. 1996Value of somatostatin receptor scintigraphy for preoperative localization of carcinoidsWorld J Surg20162167CrossRefPubMed
go back to reference Scherubl, H, Bader, M, Fett, U, et al. 1993Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumorsGastroenterology10517051709PubMed Scherubl, H, Bader, M, Fett, U,  et al. 1993Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumorsGastroenterology10517051709PubMed
go back to reference Schillaci, O, Spanu, A, Scopinaro, F, et al. 2003Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumorsJ Nucl Med44359368PubMed Schillaci, O, Spanu, A, Scopinaro, F,  et al. 2003Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumorsJ Nucl Med44359368PubMed
go back to reference Lebtahi, R, Cadiot, G, Sarda, L, et al. 1997Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumorsJ Nucl Med38853858PubMed Lebtahi, R, Cadiot, G, Sarda, L,  et al. 1997Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumorsJ Nucl Med38853858PubMed
go back to reference Krausz, Y, Bar-Ziv, J, de Jong, RB, et al. 1998Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumorsAm J Gastroenterol936670CrossRefPubMed Krausz, Y, Bar-Ziv, J, de Jong, RB,  et al. 1998Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumorsAm J Gastroenterol936670CrossRefPubMed
go back to reference Briganti, V, Matteini, M, Ferri, P, et al. 2001Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumorsCancer Biother Radiopharm16515524CrossRefPubMed Briganti, V, Matteini, M, Ferri, P,  et al. 2001Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumorsCancer Biother Radiopharm16515524CrossRefPubMed
go back to reference Chiti, A, Fanti, S, Savelli, G, et al. 1998Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumoursEur J Nucl Med2513961403CrossRefPubMed Chiti, A, Fanti, S, Savelli, G,  et al. 1998Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumoursEur J Nucl Med2513961403CrossRefPubMed
go back to reference Lamberts, SW, Reubi, JC, Krenning, EP 1993Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumorsActa Oncol32167170PubMed Lamberts, SW, Reubi, JC, Krenning, EP 1993Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumorsActa Oncol32167170PubMed
go back to reference Krenning, EP, Kwekkeboom, DJ, Bakker, WH, et al. 1993Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1] [123I-Tyr3]- and [111In-DTPA-D-Phe1] [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEur J Nucl Med20716731PubMed Krenning, EP, Kwekkeboom, DJ, Bakker, WH,  et al. 1993Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1] [123I-Tyr3]- and [111In-DTPA-D-Phe1] [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEur J Nucl Med20716731PubMed
go back to reference Oliaro, A, Filosso, PL, Bello, M, et al. 1997Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary resultsJ Cardiovasc Surg (Torino)38313315 Oliaro, A, Filosso, PL, Bello, M,  et al. 1997Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary resultsJ Cardiovasc Surg (Torino)38313315
Metadata
Title
Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS
Authors
B. Kumbasar
I. R. Kamel
A. Tekes
J. Eng
E. K. Fishman
R. L. Wahl
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 6/2004
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-003-0162-3

Other articles of this Issue 6/2004

Abdominal Radiology 6/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.